Although limited information is available regarding the impact of heparanase on AD pathogenesis, Aβ40 has been shown to protect heparanase-catalyzed degradation of HSPGs in vitro with predicted effect contributing to the stability and persistence of Aβ plaques [53]. The gene discussed is HPSE; the disease is Alzheimer disease.